Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2010
03/18/2010US20100068807 INTERFERON-alpha REGULATOR
03/18/2010US20100068762 Novel nucleic acid molecules
03/18/2010US20100068761 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
03/18/2010US20100068742 Methods
03/18/2010US20100068736 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung Cancer
03/18/2010US20100068732 Cloned glucagon-like peptide-2 receptors
03/18/2010US20100068731 Use of N-Myristoyltransferase on Non-Tumor Tissue for Cancer Diagnosis
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100068215 Use of GDF traps to increase red blood cell levels
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068212 Targeting pathogenic monocytes
03/18/2010US20100068208 Degranulation inhibitor
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068201 Compositions and methods for the systemic treatment of arthritis
03/18/2010US20100068199 Pcsk9 antagonists
03/18/2010US20100068198 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
03/18/2010US20100068151 Multimodality molecular imaging with therapeutic conjugates
03/18/2010US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential
03/18/2010US20100068137 Dock-and-Lock (DNL) Vaccines for Cancer Therapy
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010CA2737056A1 Targeting pathogenic monocytes
03/18/2010CA2736829A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2736816A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2736479A1 Lcms technology and its uses
03/18/2010CA2736349A1 Pcsk9 antagonists
03/18/2010CA2736277A1 Display library for antibody selection
03/18/2010CA2735881A1 Monoclonal antibodies specific for pancreatic neoplasia cells
03/18/2010CA2734694A1 Methods for inhibiting ocular angiogenesis
03/17/2010EP2163898A1 Method for detection of L523S expression in biological samples
03/17/2010EP2163896A1 Method for detection or treatment of graft versus host disease
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163628A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163625A1 IL-17 and IL-17R homologous polypeptides and therapeutic uses thereof
03/17/2010EP2163623A2 Bitter taste receptors
03/17/2010EP2163564A1 Cancerous disease modifying antibodies
03/17/2010EP2163563A1 Treatment of tumors expressing mutant EGF receptors
03/17/2010EP2163562A2 IL-1beta binding antibodies and fragments thereof
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163257A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP2162743A2 Methods of modulating inflammation and compositions therefore
03/17/2010EP2162472A2 Immunoglobulin fusion proteins
03/17/2010EP2162471A1 Compositions and methods for treating pancreatic tumors
03/17/2010EP2162470A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
03/17/2010EP2162469A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
03/17/2010EP2162468A2 Polypeptides, antibody variable domains & antagonists
03/17/2010EP2162467A2 Polypeptides, antibody variable domains & antagonists
03/17/2010EP2162466A2 Polypeptides, antibody variable domains & antagonists
03/17/2010EP2162465A2 Polypeptides, antibody variable domains & antagonists
03/17/2010EP2162133A1 Methods for reducing allergies caused by environmental allergens
03/17/2010EP1664300B1 A new class of a2delta calcium channel subunits
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010EP1027439B1 Multivalent antigen-binding proteins
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101675079A Binding members for ige molecules
03/17/2010CN101675078A crig antagonists
03/17/2010CN101675077A cross-species-specific bispecific binders
03/17/2010CN101675076A engineered anti-il-23r antibodies
03/17/2010CN101675075A Recombinant anti-epidermal growth factor receptor antibody compositions
03/17/2010CN101675074A antibodies and methods for making and using them
03/17/2010CN101671654A Monoclonal antibody resisting anaplasma marginale MSP5 protein and application thereof
03/17/2010CN101671394A Antibody of anti hAPE1 protein and preparation method thereof as well as kit applying antibody
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671392A Monoclonal antibody resisting hemocyanin of China prawns as well as preparation method and application thereof
03/17/2010CN101671391A Rhodamine B artificial antigen and preparation method and application thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/17/2010CN101670105A Humanized antibodies chelated with amylord beta peptide
03/17/2010CN100594037C Complement receptor 2 targeted complement modulators
03/16/2010US7678893 Fluorescent proteins from Copepoda species and methods for using same
03/16/2010US7678891 Antibodies that bind CCX-CKR2
03/16/2010US7678889 monoclonal antibody for identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and noncancerous disease states in the ovary
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678886 increased recombinant protein expression levels, solubility, soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics
03/16/2010US7678822 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases
03/16/2010US7678775 ILK inhibitors for the treatment of renal disease
03/16/2010US7678760 Inhibitors of Memapsin 2 and use thereof
03/16/2010US7678759 Diagnosis and treatment of neuroectodermal tumors
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678551 include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties; antiepileptic drug, bipolar diseases; kits
03/16/2010US7678386 Liposomes coated with selected antibodies that bind to aminophospholipids
03/16/2010US7678373 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
03/16/2010US7678372 Tyrosine kinase inhibitors; anticancer agents; genetic engineered protein
03/16/2010CA2296766C Aggrecan degrading metallo proteases
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/16/2010CA2191577C Method for treating and preventing atherosclerosis
03/11/2010WO2010028306A2 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions
03/11/2010WO2010028072A2 Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
03/11/2010WO2010027981A1 Multispecific antibodies
03/11/2010WO2010027903A2 Lung cancer diagnosis
03/11/2010WO2010027818A2 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
03/11/2010WO2010027797A1 T-cell receptor antibodies and methods of use thereof
03/11/2010WO2010027767A1 Engineered anti-il-23r antibodies
03/11/2010WO2010027766A1 Lyophilized formulatons of engineered anti-il-23p19 antibodies
03/11/2010WO2010027499A2 Methods, compositions and vaccines relating to neisseria meningitidis antibodies
03/11/2010WO2010027488A2 Monoclonal antibodies
03/11/2010WO2010027370A1 Compositions and methods for the treatment of solid tumor cancers
1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 1494